ClinicalTrials.Veeva

Menu

Prospective, Randomized, Controlled Agreement and Reproducibility Clinical Study

V

Visibly

Status

Completed

Conditions

Digital Acuity Product

Treatments

Device: Visibly Digital Acuity Product

Study type

Interventional

Funder types

Industry

Identifiers

NCT05026658
VDAP-1002

Details and patient eligibility

About

Visual acuity is the relative ability of the eye to resolve detail that is usually expressed as the reciprocal of the minimum angular separation in minutes of two lines just resolvable as separate and that forms in the average human eye an angle of one minute.

Visibly Inc. has developed a method for determining a patient's visual acuity electronically via a web-based software system that can be self-administered wherever convenient. This method provides an efficient alternative for people to have immediate access to visual acuity measurements.

Full description

The Visibly Digital Acuity Product (VDAP) is a web-based, self-guided software application intended for use by adults, ages 22 to 40, at home, to evaluate visual acuity with or without correction. The standalone software application allows the user to interface with the software via a web browser on two internet-enabled devices:

  • A computer screen (the Display) which displays optotypes
  • A touchscreen mobile device (the Remote) which operates as a remote control and interface for the user to respond to prompts related to the optotypes appearing on the Display while standing 10 feet away

The software allows users to view and respond to displayed optotypes and uses the responses to categorize a user's visual acuity into one of two buckets:

  • 20/25 or better
  • Worse than 20/25

Enrollment

358 patients

Sex

All

Ages

22 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

    1. Be between 22 and 40 years (inclusive) of age at the time of consent 2. Be able and willing to provide written informed consent, attend all scheduled visits and comply with all study procedures

Exclusion criteria

    1. Have any of the following conditions (based on subject report):

    2. Advanced eye disease in either eye;

    3. Poor vision as a result of refractive surgery in either eye;

    4. Unable to walk;

    5. Unable to hear or follow audio instructions.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

358 participants in 2 patient groups

Visibly Digital Acuity Product
Experimental group
Treatment:
Device: Visibly Digital Acuity Product
ETDRS Visual Acuity Lane Test
Experimental group
Treatment:
Device: Visibly Digital Acuity Product

Trial contacts and locations

3

Loading...

Central trial contact

Paul Foley

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems